Patent · US Active

Compounds having CRTH2 antagonist activity

US8563536B2 · kind B2 · utility

8Cited by
31References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 31, 2011
Grant dateOct 22, 2013
Priority date—
Expiry dateJan 31, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of general formula (II)wherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.